v3.26.1
Fair Value Measurements - Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments (Details) - Level 3 [Member] - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Mar. 31, 2026
Sep. 30, 2025
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 240,658 $ 224,187
Senior Secured First Lien Term Loans [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 85,193 $ 74,485
Valuation Methodology Income Approach Income Approach
Unobservable Input Market Yield Market Yield
Range (Weighted Average) 4.5% - 21.0% (11.3%) 3.3% - 14.5% (10.0%)
Impact to Valuation From An Increase In Input Decrease Decrease
Senior Secured First Lien Term Loans Two [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 9,742 $ 997
Valuation Methodology Market Approach Market Approach
Unobservable Input EBITDA Multiple Market Spread
Range (Weighted Average) 2.8x - 3.8x (3.3x) 4.8% - 5.5% (5.1%)
Impact to Valuation From An Increase In Input Increase Increase
Senior Secured First Lien Term Loans Three [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 71 $ 71
Valuation Methodology Recent Transaction Recent Transaction
Unobservable Input Purchase Price Purchase Price
Range (Weighted Average) N/A N/A
Impact to Valuation From An Increase In Input N/A N/A
Senior Secured Notes [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 6,997 $ 6,997
Valuation Methodology Cost Approach Cost Approach
Unobservable Input Collateral Value Collateral Value
Range (Weighted Average) N/A N/A
Impact to Valuation From An Increase In Input N/A N/A
Equity/Warrants [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 85,199 $ 78,255
Valuation Methodology Market Approach Market Approach
Unobservable Input EBITDA Multiple EBITDA Multiple
Range (Weighted Average) 1.1x - 14.0x (4.5x) 1.3x - 13.0x (11.0x)
Impact to Valuation From An Increase In Input Increase Increase
Equity/Warrants Five [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 36,796 $ 100
Valuation Methodology Cost Approach Cost Approach
Unobservable Input Replacement Cost Collateral Value
Range (Weighted Average) N/A N/A
Impact to Valuation From An Increase In Input N/A N/A
Equity/Warrants Two [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 6,655 $ 3,948
Valuation Methodology Market Approach Market Approach
Unobservable Input Revenue Multiple Market Quote
Range (Weighted Average) 4.0x-5.0x (4.5x) N/A
Impact to Valuation From An Increase In Input Increase N/A
Equity/Warrants Three [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 9,905 $ 6,000
Valuation Methodology Income Approach Market Approach
Unobservable Input Market Yield Revenue Multiple
Range (Weighted Average) 7.6%-28.8% (16.5%) 2.5x-3.0x (2.8x)
Impact to Valuation From An Increase In Input Decrease Increase
Equity/Warrants Four [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value $ 100 $ 2,725
Valuation Methodology Cost Approach Income Approach
Unobservable Input Collateral Value Market Yield
Range (Weighted Average) N/A 28.3% - 28.8% (28.5%)
Impact to Valuation From An Increase In Input N/A Decrease
Senior Secured First Lien Term Loans One [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value   $ 13,428
Valuation Methodology   Market Approach
Unobservable Input   EBITDA Multiple
Range (Weighted Average)   1.8x - 2.8x (2.3x)
Impact to Valuation From An Increase In Input   Increase
Equity/Warrants One [Member]    
Schedule of Quantitative Information About Level 3 Fair Value Measurements of Our Investments [Line Items]    
Fair Value   $ 37,181
Valuation Methodology   Cost Approach
Unobservable Input   Replacement Cost
Range (Weighted Average)   N/A
Impact to Valuation From An Increase In Input   N/A